Kura Oncology KURA
NASDAQ KURA
$10.65 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kura Oncology (KURA) Interest Expenses (2010 - 2026)

Updated

Kura Oncology (KURA) reported Interest Expenses of $345,000 for Q2 2026, down 11.8% from $391,000 a year earlier but up 2.7% from the prior quarter.

Analysis

Kura Oncology (KURA) Interest Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kura Oncology's Interest Expenses came in at $1.42 million, down 10.6% year-over-year; for FY2025, it came in at $1.51 million, down 6.6% from FY2024.

  • Interest Expenses has a five-year compound annual growth rate of 21.2% (FY2020 to FY2025).
  • By year, Interest Expenses came in at $1.62 million in FY2024 (+4.5%), $1.55 million in FY2023 (+576.4%), $229,000 in FY2022 (-44.7%) and $414,000 in FY2021 (-28.4%).
  • Five-year quarterly Interest Expenses spans a low of $336,000 in Q1 2026 and a high of $412,000 in Q3 2024.
  • Year over year, Interest Expenses has now declined in each of the last six quarters, with an average decline of 5.8% over the last eight quarters.
  • The high point for year-over-year Interest Expenses in five years was Q1 2024 (growth of 9.3%); the low point was Q4 2025 (a decline of 14.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $336,000 (Q1 2026), $346,000 (Q4 2025) and $393,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Kura Oncology 947.36 Mn 947.36 Mn 20.63 Mn 345,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 345,000.00
Mar 31, 2026 336,000.00
Dec 31, 2025 346,000.00
Sep 30, 2025 393,000.00
Jun 30, 2025 391,000.00
Mar 31, 2025 382,000.00
Dec 31, 2024 403,000.00
Sep 30, 2024 412,000.00
Jun 30, 2024 406,000.00
Mar 31, 2024 398,000.00
Dec 31, 2023 394,000.00
Sep 30, 2023 404,000.00
Jun 30, 2023 387,000.00
Mar 31, 2023 364,000.00
Jun 30, 2021 306,000.00
Mar 31, 2021 108,000.00
Dec 31, 2020 144,000.00
Sep 30, 2020 146,000.00
Jun 30, 2020 144,000.00
Mar 31, 2020 144,000.00
API Access

Kura Oncology Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=KURA&period=max&api_key=YOUR_API_KEY